摘要
神经退行性疾病(NDD)如阿尔茨海默病,帕金森氏病和亨廷顿氏病是一组异质性疾病,伴有神经元的进行性和严重性丧失。对于这些疾病没有完全的证据治疗,只有可以减轻某些症状的药物。为NDD开发有效的治疗方法是一项艰巨但必要的任务。因此,调查适用于许多NDD的目标的单萜类化合物具有高度相关性。许多单萜类化合物已经证明了由各种系统介导的有希望的神经保护活性。它可以形成制剂的基础,这对于减轻NDD症状和治疗疾病进展以及预防神经变性都是有用的。需要进一步开发包括检测具有高神经保护或神经营养活性的单萜类化合物及其衍生物以及合格临床试验的结果,以得出关于这些药物功效的可靠结论。
关键词: 乙酰胆碱酯酶抑制剂,阿尔茨海默病,大麻素,亨廷顿病,单萜,单萜类,神经保护活性,帕金森病。
Current Medicinal Chemistry
Title:Application of Monoterpenoids and their Derivatives for Treatment of Neurodegenerative Disorders
Volume: 25 Issue: 39
关键词: 乙酰胆碱酯酶抑制剂,阿尔茨海默病,大麻素,亨廷顿病,单萜,单萜类,神经保护活性,帕金森病。
摘要: Neurodegenerative disorders (NDDs) like Alzheimer's disease, Parkinson’s disease and Huntington’s disease are a heterogeneous group of disorders with the progressive and severe loss of neurons. There are no full proof cures for these diseases, and only medicines are available that can alleviate some of the symptoms. Developing effective treatments for the NDDs is a difficult but necessary task. Hence, the investigation of monoterpenoids which modulate targets applicable to many NDDs is highly relevant. Many monoterpenoids have demonstrated promising neuroprotective activity mediated by various systems. It can form the basis for elaboration of agents which will be useful both for the alleviation of symptoms of NDDs and for the treatment of diseases progression and also for prevention of neurodegeneration. The further developments including detections of monoterpenoids and their derivatives with high neuroprotective or neurotrophic activity as well as the results of qualified clinical trials are needed to draw solid conclusions regarding the efficacy of these agents.
Export Options
About this article
Cite this article as:
Application of Monoterpenoids and their Derivatives for Treatment of Neurodegenerative Disorders, Current Medicinal Chemistry 2018; 25 (39) . https://dx.doi.org/10.2174/0929867324666170112101837
DOI https://dx.doi.org/10.2174/0929867324666170112101837 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Multifunctional Anti-inflammatory Drugs Used in the Therapy of Alzheimer’s Disease
Current Medicinal Chemistry Aging as an Epigenetic Phenomenon
Current Genomics Cognitive Impairment and Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Advanced Glycation End Products, Oxidative Stress and Metalloproteinases are altered in the Cerebral Microvasculature during Aging
Current Neurovascular Research Driving Cellular Plasticity and Survival Through the Signal Transduction Pathways of Metabotropic Glutamate Receptors
Current Neurovascular Research Chemoinformatics Profiling of the Chromone Nucleus as a MAO-B/A2AAR Dual Binding Scaffold
Current Neuropharmacology Overview of PCTK3/CDK18: A Cyclin-Dependent Kinase Involved in Specific Functions in Post-Mitotic Cells
Current Medicinal Chemistry Meet Our Associate Editor:
Current Alzheimer Research Aquaporins and Neurodegenerative Diseases
Current Neuropharmacology East Meets West in the Search for Alzheimers Therapeutics - Novel Dimeric Inhibitors from Tacrine and Huperzine A
Current Alzheimer Research Tubulin-Independent Tau in Alzheimer’s Disease and Cancer: Implications for Disease Pathogenesis and Treatment
Current Alzheimer Research Aromatherapy and the Central Nerve System (CNS): Therapeutic Mechanism and its Associated Genes
Current Drug Targets The Regulatory Effects of Glutamine on Illness and Health
Protein & Peptide Letters Mechanism of Action of Flavonoids as Anti-inflammatory Agents: A Review
Inflammation & Allergy - Drug Targets (Discontinued) Synthesis of Propargylamines by Cross-Dehydrogenative Coupling
Current Green Chemistry Tau Oligomerization: A Role for Tau Aggregation Intermediates Linked to Neurodegeneration
Current Alzheimer Research Bacteriophage - A Common Divergent Therapeutic Approach for Alzheimer's Disease and Type II Diabetes Mellitus
CNS & Neurological Disorders - Drug Targets Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders
CNS & Neurological Disorders - Drug Targets Hydrogen Sulfide in Physiological and Pathological Mechanisms in Brain
CNS & Neurological Disorders - Drug Targets Alzheimer’s Disease Amyloid Peptides Interact with DNA, As Proved by Surface Plasmon Resonance
Current Alzheimer Research